Literature DB >> 10590131

Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export.

L L Poon1, E Fodor, G G Brownlee.   

Abstract

The poly(A) tail of influenza virus mRNA is synthesized by reiterative copying of a U track near the 5' end of the virion RNA (vRNA) template by the viral RNA polymerase. We have engineered a novel influenza A/WSN/33 virus which contains a neuraminidase (NA) vRNA with its U track mutated into an A track. Instead of synthesizing poly(A)-tailed NA mRNA, this novel virus synthesizes poly(U)-tailed NA mRNA. In infected cells, most poly(U)-tailed NA mRNA was retained in the nucleus, while most control polyadenylated NA mRNA was transported to the cytoplasm. These results suggest that the poly(A) tail is important for efficient nuclear export of NA mRNA. The mutant virus produced a reduced amount of NA and showed an attenuated phenotype, suggesting that poly(A) signal mutants of this type might be useful as potential live attenuated virus vaccines. In addition, this virus mutant might provide a useful model to further elucidate the basic mechanisms of mRNA nuclear export.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590131      PMCID: PMC111553          DOI: 10.1128/jvi.74.1.418-427.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  The RNA polymerase of influenza virus, bound to the 5' end of virion RNA, acts in cis to polyadenylate mRNA.

Authors:  L L Poon; D C Pritlove; J Sharps; G G Brownlee
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 2.  Nucleocytoplasmic transport: the soluble phase.

Authors:  I W Mattaj; L Englmeier
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

3.  Attenuation of influenza A virus mRNA levels by promoter mutations.

Authors:  E Fodor; P Palese; G G Brownlee; A García-Sastre
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 4.  Transport of macromolecules between the nucleus and the cytoplasm.

Authors:  E Izaurralde; S Adam
Journal:  RNA       Date:  1998-04       Impact factor: 4.942

5.  A hairpin loop at the 5' end of influenza A virus virion RNA is required for synthesis of poly(A)+ mRNA in vitro.

Authors:  D C Pritlove; L L Poon; L J Devenish; M B Leahy; G G Brownlee
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

7.  Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.

Authors:  P Palese; R W Compans
Journal:  J Gen Virol       Date:  1976-10       Impact factor: 3.891

8.  Influenza virion transcriptase: synthesis in vitro of large, polyadenylic acid-containing complementary RNA.

Authors:  S J Plotch; R M Krug
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

9.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.

Authors:  A García-Sastre; A Egorov; D Matassov; S Brandt; D E Levy; J E Durbin; P Palese; T Muster
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

10.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.

Authors:  M E Nemeroff; S M Barabino; Y Li; W Keller; R M Krug
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

View more
  14 in total

1.  Messenger RNAs that are not synthesized by RNA polymerase II can be 3' end cleaved and polyadenylated.

Authors:  E Fodor; A Mikulasova; L J Mingay; L L Poon; G G Brownlee
Journal:  EMBO Rep       Date:  2000-12       Impact factor: 8.807

2.  3D structure of the influenza virus polymerase complex: localization of subunit domains.

Authors:  Estela Area; Jaime Martín-Benito; Pablo Gastaminza; Eva Torreira; José M Valpuesta; José L Carrascosa; Juan Ortín
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-22       Impact factor: 11.205

3.  Mutations in the N-terminal region of influenza virus PB2 protein affect virus RNA replication but not transcription.

Authors:  Pablo Gastaminza; Beatriz Perales; Ana M Falcón; Juan Ortín
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Regulation of influenza RNA polymerase activity and the switch between replication and transcription by the concentrations of the vRNA 5' end, the cap source, and the polymerase.

Authors:  Andrew C Olson; Eric Rosenblum; Robert D Kuchta
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

5.  Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles.

Authors:  Urtzi Garaigorta; Ana M Falcón; Juan Ortín
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 6.  Poly(A) RNA-binding proteins and polyadenosine RNA: new members and novel functions.

Authors:  Callie P Wigington; Kathryn R Williams; Michael P Meers; Gary J Bassell; Anita H Corbett
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-04-30       Impact factor: 9.957

7.  A small-RNA enhancer of viral polymerase activity.

Authors:  Jasmine T Perez; Ivan Zlatev; Shilpa Aggarwal; Sailakshmi Subramanian; Ravi Sachidanandam; Baek Kim; Muthiah Manoharan; Benjamin R tenOever
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 8.  Influenza A: understanding the viral life cycle.

Authors:  Tasleem Samji
Journal:  Yale J Biol Med       Date:  2009-12

Review 9.  Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis.

Authors:  Aartjan J W Te Velthuis; Ervin Fodor
Journal:  Nat Rev Microbiol       Date:  2016-07-11       Impact factor: 60.633

10.  The splicing factor proline-glutamine rich (SFPQ/PSF) is involved in influenza virus transcription.

Authors:  Sara Landeras-Bueno; Núria Jorba; Maite Pérez-Cidoncha; Juan Ortín
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.